RA Messages for September 3, 2002


PHARMACY PROVIDERS, PLEASE NOTE!!!

IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG PRODUCT, PLEASE CONTACT THE PBM HELP DESK AT 1-800-648-0790


PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/01/02 VERSION OF APPENDIX A:

DRUG   DOSAGE STRENGTH MAC EFF DATE 
ALLOPURINOL TABLET    300MG 0.16710 08/01/02 
AMANTADINE HCL  CAPSULE 100MG 0.24630     08/01/02 
AMITRIPTYLINE HCL TABLET  10MG 0.08910  08/01/02 
AMITRIPTYLINE HCL TABLET 25MG 0.09360  08/01/02 
AMPICILLIN TRIHYDRATE  CAPSULE  250MG  0.11930  08/01/02 
AMPICILLIN TRIHYDRATE CAPSULE  500MG 0.21285  08/01/02 
BUMETANIDE  TABLET 1MG  0.23480 08/01/02 
BUMETANIDE TABLET 2MG 0.42720  08/01/02 
DESIPRMINE HCL  TABLET 10MG  0.25950 08/01/02 
DESIPRMINE HCL   TABLET  25MG   0.27900  08/01/02 
DESIPRMINE HCL TABLET  50MG  0.59340 08/01/02 
DESIPRMINE HCL  TABLET  75MG  0.72050 08/01/02 
DESIPRMINE HCL TABLET  100MG 1.10100 08/01/02 
HYDROXUREA  CAPSULE 500MG OFF MAC 08/01/02 
HYDROXYZINE HCL  TABLET   10MG 0.10130 08/01/02 
HYDROXYZINE HCL   TABLET   25MG  0.14930 08/01/02 
HYDROXYZINE HCL  TABLET   50MG 0.18655  08/01/02 
METHOCARBAMOL TABLET   750MG OFF MAC 08/01/02 

  PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/01/02 VERSION OF APPENDIX B:

NDC TRADENAME DOSAGE 
64248-0120-10  MIDRIN   CAPSULE

PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/01/02 VERSION OF APPENDIX C:

LABELER COMPANY BEGIN  END
00033 SYNTEX LABORATORIES, INC    10/01/02
00113 PERRIGO COMPANY    10/01/02
00268 CENTER LABORATORIES   10/01/02
00349 PARMED PHARM.   10/01/02
00710 PFIZER PHARMACEUTICALS   10/01/02
10797 LUITPOLD PHARM.   10/01/02
50057 PHARMACEUTICAL VENTURES    10/01/02
52446 QUALITEST PHARM.   10/01/02
53124 PRAXIS BIOLOGICS   10/01/02
53404 VINTAGE PHARM.   10/01/02
57294 SMITHKLINE BEECHAM   10/01/02
58441 INSOURCE, INC   10/01/02
58728 PETERS LABORATORIES, INC   10/01/02
63254 EM PHARMA   10/01/02
64909 ZOETICA PHARMACEUTICAL CORPORATION   10/01/02
66500 NOVAVAX, INC 10/01/02  
66582 MSP MARKETING SERVICES 10/01/02  
66663 PHARMELLE CORPORATION 10/01/02  
66689 VISTAPHARM, INC. 10/01/02   
66758 PARENTA PHARM. 10/01/02   
66992 WRASER PHARM. 10/01/02   
67197 FOR EVER YOUNG PRODUCTS, INC 10/01/02   
67211 PHARMION CORPORATION 10/01/02   

PLEASE FILE ADJUSTMENTS FOR CLAIMS WHICH MAY HAVE BEEN INCORRECTLY PAID.


NOTICE TO ALL PROVIDERS

IN REGARDS TO THE FOLLOWING MESSAGE RELATED TO BILLING FOR EMERGENCY ROOM SERVICES, SENT FOR THE WEEK OF 8/6/02 AND 8/13/02, THE PROGRAMMING FOR EMC WAS NOT COMPLETED WHEN THIS MESSAGE WAS SENT AND DATA PLACED IN FORM LOCATOR 11 OF THE UB92 WAS NOT RECOGNIZED BY THE SYSTEM IF BILLED ELECTRONICALLY. THIS PROGRAMMING IS COMPLETED AND THE EMC PROVIDERS ARE BEING NOTIFIED OF APPROPRIATE SOFTWARE BILLING CHANGES. PROVIDERS ARE RESPONSIBLE FOR RESUBMITTING FOR ANY CLAIMS THAT WERE NOT PROCESSED CORRECTLY. 

EFFECTIVE JULY 1, 2002,EMERGENCY DEPARTMENT PHYSICIAN VISITS OF MODERATE TO HIGH COMPLEXITY (CPT 99283, 99284, AND 99285,99291, 99292, 99243, 99244, 99245), AND ASSOCIATED HOSPITAL SERVICES WILL BE EXEMPT FROM THE COMMUNITYCARE POST-AUTHORIZATION PROCESS. 

HOSPITALS BILLING FOR SERVICES ASSOCIATED WITH MODERATE TO HIGH LEVEL EMERGENCY PHYSICIAN CARE, SHOULD PLACE A "3" IN FORM LOCATOR 11 ON THE UB92. MODERATE TO HIGH LEVEL COMPLEXITY SHOULD CORRESPOND TO THE LEVEL OF CARE NOTED IN THE DEFINITION OF EVALUATION AND MANAGEMENT CPT CODES 99283, 99284, 99285. PROVIDERS ARE RESPONSIBLE FOR SUBMITTING ADJUSTMENTS FOR ANY CLAIMS PAID INCORRECTLY. 

HOSPITALS BILLING FOR SERVICES ASSOCIATED WITH LOW LEVEL EMERGENCY PHYSICIAN CARE, SHOULD PLACE A "1" IN FORM LOCATOR 11 ON THE UB92. LOW LEVEL COMPLEXITY SHOULD CORRESPOND TO THE LEVEL OF CARE NOTED IN THE DEFINITION OF EVALUATION AND MANAGEMENT CPT CODES 99281, 99282. WHEN AN ENROLLEE IS HOSPITALIZED OR RECEIVES SERVICES IN THE ER, IT IS THE HOSPITAL'S RESPONSIBILITY TO ENSURE THAT THE PCP'S AUTHORIZATION NUMBER IS AVAILABLE FOR ANY OTHER PROVIDERS THAT WILL BILL MEDICAID FOR SERVICES RELATED TO THE HOSPITAL ADMISSION OR ER VISIT.